Ledger.Open graph →

SEC Form D · filed May 27, 2020

GVB Biopharma

Offering

$3.0M

Sold

$1.3M

Exemption

Rule 506(b)

Industry

Manufacturing

Location

LAS VEGAS, NV

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Theodore Swindells · Las Vegas, NVDirector Phillip Swindells · Las Vegas, NVExec · Director Jack Feldman · Las Vegas, NVExec · Director William Spiegel · Las Vegas, NVExec · Director John J. D'Agostino · New York, NYExec · Director Chester S. Zygmont Iii · San Diego, CADirector Eric Chen · Los Altos, CAExec · Director Scott Craven Jones · Kenilworth, ILExec · Director Todd Davis · Newport Beach, CAExec · Director Doug Weekes · Newport Beach, CAExec · Director Ben Mandell · Miami, FLExec · Director Scott Sherman · Miami, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗